Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001753926-24-002049
Filing Date
2024-12-06
Accepted
2024-12-06 16:09:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A g084586_defa14a.htm DEFA14A 36213
  Complete submission text file 0001753926-24-002049.txt   37361
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41575 | Film No.: 241532353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)